tradingkey.logo
tradingkey.logo
Suchen

Myomo Inc

MYO
Zur Watchlist hinzufügen
0.910USD
+0.026+2.97%
Handelsschluss 05/15, 16:00ETKurse um 15 Minuten verzögert
35.17MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Myomo Inc Unternehmen

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Myomo Inc Informationen

BörsenkürzelMYO
Name des UnternehmensMyomo Inc
IPO-datumJun 12, 2017
CEOGudonis (Paul R)
Anzahl der mitarbeiter184
WertpapierartOrdinary Share
GeschäftsjahresendeJun 12
Addresse137 Portland Street
StadtBOSTON
BörseNASDAQ OMX – NASDAQ Basic Amex
LandUnited States of America
Postleitzahl02114
Telefon16179969058
Websitehttps://myomo.com/
BörsenkürzelMYO
IPO-datumJun 12, 2017
CEOGudonis (Paul R)

Führungskräfte von Myomo Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.11M
-13.32%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
553.86K
--
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
358.41K
-21.82%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
131.75K
--
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
80.99K
-73.62%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.11M
-13.32%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
553.86K
--
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
358.41K
-21.82%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
131.75K
--
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
80.99K
-73.62%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025Q3
FY2025Q2
FY2025Q1
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Direct to patient
7.32M
72.56%
Clinical/Medical providers
2.77M
27.44%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Direct to patient
7.32M
72.56%
Clinical/Medical providers
2.77M
27.44%

Aktionärsstatistik

Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Rosalind Advisors, Inc.
9.94%
Horton Capital Management LLC
5.07%
BlackRock Institutional Trust Company, N.A.
3.96%
Vanguard Capital Management, LLC
2.96%
Gudonis (Paul R)
2.88%
Andere
75.19%
Aktionäre
Aktionäre
Anteil
Rosalind Advisors, Inc.
9.94%
Horton Capital Management LLC
5.07%
BlackRock Institutional Trust Company, N.A.
3.96%
Vanguard Capital Management, LLC
2.96%
Gudonis (Paul R)
2.88%
Andere
75.19%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
16.43%
Investment Advisor
12.82%
Investment Advisor/Hedge Fund
7.64%
Individual Investor
6.78%
Research Firm
4.41%
Venture Capital
0.42%
Bank and Trust
0.14%
Pension Fund
0.12%
Family Office
0.03%
Andere
51.20%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
185
23.44M
63.19%
-5.84M
2025Q4
169
22.12M
57.56%
-3.94M
2025Q3
153
21.95M
58.07%
-1.84M
2025Q2
131
25.59M
71.13%
+1.42M
2025Q1
128
23.88M
66.62%
+977.96K
2024Q4
112
23.29M
69.71%
+5.81M
2024Q3
85
19.54M
71.85%
+1.13M
2024Q2
79
18.43M
69.76%
+448.58K
2024Q1
77
16.43M
64.97%
-1.27M
2023Q4
72
14.80M
62.04%
-346.58K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Rosalind Advisors, Inc.
3.84M
9.97%
+48.98K
+1.29%
Dec 31, 2025
Horton Capital Management LLC
1.96M
5.09%
+1.96M
--
Dec 24, 2025
BlackRock Institutional Trust Company, N.A.
1.53M
3.97%
+34.56K
+2.31%
Dec 31, 2025
Gudonis (Paul R)
1.26M
3.27%
+11.64K
+0.93%
Jan 12, 2026
Geode Capital Management, L.L.C.
736.97K
1.91%
-67.47K
-8.39%
Dec 31, 2025
Jefferies LLC
704.27K
1.83%
+704.27K
--
Dec 31, 2025
Kirk (Thomas F)
553.86K
1.44%
+72.00K
+14.94%
Mar 13, 2026
Goldman Sachs & Company, Inc.
466.70K
1.21%
-566.87K
-54.85%
Dec 31, 2025
AQR Capital Management, LLC
434.38K
1.13%
+140.43K
+47.77%
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Micro-Cap ETF
Anteil0.01%
ProShares Hedge Replication ETF
Anteil0%
iShares Russell 2000 ETF
Anteil0%
iShares Russell 2000 Growth ETF
Anteil0%
Global X Russell 2000 ETF
Anteil0%
Proshares Ultra Russell 2000
Anteil0%
ProShares UltraPro Russell2000
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI